This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/02/15 - 1:13:12 PM ET (BATS BZX Real-time Price)
Div Yield: --
XOMA Day's Range
XOMA 52 Week Range
XOMA Business Summary
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific.View XOMA key stats
XOMA Corp - XOMA - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates XOMA Corp as a
Sell with a ratings score of D-.
Report Snippet: We rate XOMA CORP (XOMA) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and generally disappointing historical performance in the stock itself.